Sabo T, Lomnitski L, Nyska A, Beni S, Maronpot R R, Shohami E, Roses A D, Michaelson D M
Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, 69978, Ramat Aviv, Israel.
Neuroscience. 2000;101(4):879-84. doi: 10.1016/s0306-4522(00)00438-3.
Apolipoprotein E, the major brain lipid-binding protein, is expressed in humans as three common isoforms (E2, E3 and E4). Previous studies revealed that the allele apolipoprotein E4 is a major genetic risk factor of Alzheimer's disease and that traumatic brain injury is associated with increased risk for developing this disease. Furthermore, it has been suggested that the effects of traumatic head injury and apolipoprotein E4 in Alzheimer's disease are synergistic. To test the hypothesis that the apolipoprotein E genotype affects susceptibility to brain injury, we subjected transgenic mice, expressing either human apolipoprotein E3 or human apolipoprotein E4 on a null mouse apolipoprotein E background and apolipoprotein E-deficient knockouts, to closed head injury and compared mortality, neurological recovery and the extent of brain damage of the survivors. More than 50% of the transgenic mice expressing human apolipoprotein E4 died following closed head injury, whereas only half as many of the transgenic mice expressing human apolipoprotein E3, and of the control and apolipoprotein E-deficient mice died during this period (P<0.02). A neurological severity score used for clinical assessment of the surviving mice up to 11 days after closed head injury revealed that the four mouse groups displayed similar severity of damage at 1h following injury. At three and 11 days post-injury, however, the neurological severity scores of the transgenic mice expressing human apolipoprotein E3 were significantly lower than those of the other three groups whose scores were similar, indicating better recovery of the transgenic mice expressing human apolipoprotein E3. Histopathological examination of the mice performed 11 days post-injury revealed, consistent with the above neurological results, that the size of the damaged brain area of the transgenic mice expressing human apolipoprotein E3 was smaller than that of the other head-injured groups. These findings show that transgenic mice expressing human apolipoprotein E4 are more susceptible than those expressing apolipoprotein E3 to closed head injury. We suggest that this effect is due to both a protective effect of apolipoprotein E3 and an apolipoprotein E4-related pathological function.
载脂蛋白E是主要的脑脂质结合蛋白,在人类中以三种常见异构体(E2、E3和E4)的形式表达。先前的研究表明,载脂蛋白E4等位基因是阿尔茨海默病的主要遗传风险因素,并且创伤性脑损伤与患此病的风险增加有关。此外,有人提出创伤性头部损伤和载脂蛋白E4在阿尔茨海默病中的作用是协同的。为了检验载脂蛋白E基因型影响脑损伤易感性的假设,我们将在无载脂蛋白E的小鼠背景上表达人载脂蛋白E3或人载脂蛋白E4的转基因小鼠以及载脂蛋白E缺陷型敲除小鼠进行闭合性头部损伤,并比较了死亡率、神经功能恢复情况以及幸存者的脑损伤程度。超过50%表达人载脂蛋白E4的转基因小鼠在闭合性头部损伤后死亡,而在此期间表达人载脂蛋白E3的转基因小鼠以及对照和载脂蛋白E缺陷型小鼠的死亡数量仅为前者的一半(P<0.02)。用于对闭合性头部损伤后长达11天的存活小鼠进行临床评估的神经严重程度评分显示,四组小鼠在损伤后1小时显示出相似的损伤严重程度。然而,在损伤后3天和11天,表达人载脂蛋白E3的转基因小鼠的神经严重程度评分显著低于其他三组评分相似的小鼠,这表明表达人载脂蛋白E3的转基因小鼠恢复得更好。损伤后11天对小鼠进行的组织病理学检查显示,与上述神经学结果一致,表达人载脂蛋白E3的转基因小鼠受损脑区的大小小于其他头部受伤组。这些发现表明,表达人载脂蛋白E4的转基因小鼠比表达载脂蛋白E3的转基因小鼠对闭合性头部损伤更敏感。我们认为这种效应是由于载脂蛋白E3的保护作用和载脂蛋白E4相关的病理功能共同导致的。